The test and its applications are not the part that causes concerns, if they stated it correctly then it is the best option in the current market. That alone should guarantee sales but the problem are the women who need to be educated to do it. The GPs and oncologists won't be the problem, they are happy for everything that improves the results accuracy and comfort - they definitely will recommend the test.
Not sure whether the test can be used in hospitals as part of ongoing treatment and if it could be covered that way already. But they need TGA approval and government back up asap. But they are aware of it and as they said today, working on it.
One big argument for holding a few shares would be the high chance of a take over if some of the giants share BDX' opinion that BREASTEST and its future applications are the best test available worldwide atm.
Best retail investor strategy would be to hold a few and to buy more should the sp dip to the 8c range as some holders will get impatient over time.
GLTA
The test and its applications are not the part that causes...
Add to My Watchlist
What is My Watchlist?
